Published price vs quote-only
Shed vs MedVi: Which One Publishes Its Price? (2026)
Shed or MedVi? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 9.2 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
The choice between Shed and MedVi usually comes down to one difference that neither homepage puts in its headline.
A discount off an undisclosed number is not a price. Shed quotes after intake, while MedVi states $179 promotional first month on the way in — which makes one of these two comparable in advance and the other not.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Easier to price in advance
- MedVi — $179 promotional first month. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Quickest to start
- Shed — 2-minute approval assessment, then home delivery after clinician review.
- Easiest to pay for
- Shed — Neither publishes financing; both expect the full amount monthly.
Shed vs MedVi at a glance
The rows below are the ones that differ enough between these two to be worth your attention.
| Shed | MedVi | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | $179 promotional first month |
| Rate after promotions | not published before intake | $299/mo |
| Pricing structure | Quoted only after intake | Promotional first month, then standard rate |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide |
| Price transparency | Quote only, after intake | Published upfront |
| Membership fee | Not stated | None |
| How fast you start | 2-minute approval assessment | Simple online process, no clinic visits |
| State coverage | Not published | Not published |
| Tirzepatide | Not published | Not published |
| Patient reviews | 8,500 | 12,896 |
| eRxDoctor score | 9.9/10 | 9.2/10 |
Cost over a full course of treatment
Comparing entry prices across these two would be actively misleading, because they escalate differently. Below, both are carried out to six and twelve months so the comparison holds at the point it matters.
| Shed | MedVi | |
|---|---|---|
| First month | Not published | $179 |
| Months 2 onward | Not published | $299/mo |
| 6-month total | Not computable | $1,674 |
| 12-month total | Not computable | $3,468 |
| Best published plan | No multi-month discount published | 3-month plan at $649 — $2,592/yr |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
Pricing you can check, and pricing you cannot
MedVi publishes $179 promotional first month before intake. That is the baseline condition for comparing two programs at all.
Shed inverts that: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Personalization is a real justification, but the result is a quote delivered at the point you have already invested time in the process.
Treat Shed's quote as the start of the comparison rather than the end of it, and check specifically what happens to the number at higher doses.
Shed: what you are buying
The pitch is one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it. Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month.
You start with 2-minute approval assessment; medication arrives via home delivery after clinician review. The price behaves as quoted only after intake.
On the clinical side, continuous coaching built into every treatment plan, prescribing name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- Flexibility to choose medication type based on budget and needs
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
- Continuous coaching is integrated into treatment, not just a prescription
- Fast 2-minute approval assessment
Shed cons
- Coaching-bundled model can cost more than bare-prescription platforms
- Standard pricing is not published, you receive a personalized quote after intake
- Name-brand options carry significantly higher costs than compounded alternatives
Where it gives ground to MedVi: you cannot know what you will pay until you have finished the intake.
A closer look at MedVi
MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
The process is simple online process, no clinic visits, then fast, free shipping. On money, expect promotional first month, then standard rate — published upfront.
Behind the prescription sits 24/7 support from certified medical professionals. Available medication: compounded semaglutide.
MedVi pros
- Clinically dosed compounded semaglutide
- Low promotional first month at $179 including fast, free shipping
- Simple online process with no clinic visits required
- 24/7 support from certified medical professionals
MedVi cons
- Price increases sharply after the first month, $299 for a standalone month
- Semaglutide only, no tirzepatide option
- Compounded medication only, no branded Ozempic or Wegovy
Set beside Shed, the thing to weigh: the price roughly doubles to $299 once the promotional month ends.
Who should choose Shed, and who should choose MedVi
Choose Shed if:
- you want an FDA-approved finished medication rather than a compounded preparation
- you want continuous coaching built into every treatment plan rather than a prescription alone
- you would get real value from one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
- the level of clinical contact suits you: continuous coaching built into every treatment plan
Choose MedVi if:
- the level of clinical contact suits you: 24/7 support from certified medical professionals
- what it leads on is worth paying for in your case: a genuinely low promotional entry point with 24/7 clinical support behind it
- delivery works the way you want it to: fast, free shipping
- you want to start on their timeline: simple online process, no clinic visits
Honest trade-offs
On price. Only MedVi publishes a rate you can plan against ($179 promotional first month). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — continuous coaching built into every treatment plan against 24/7 support from certified medical professionals — and that difference is felt in week two, not week one.
On medication. Shed covers name-brand FDA-approved GLP-1 and compounded GLP-1; MedVi covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
Evidence and regulatory status
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
The FDA publishes an ongoing record of semaglutide products marketed for diabetes and weight loss, and which of them it has actually approved, per FDA.
Dosing errors are the failure mode the FDA has flagged most often with unapproved GLP-1 products, particularly where a patient draws the dose themselves, per FDA.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
Shed vs MedVi: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to MedVi, which publishes $179 promotional first month upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Is coaching included with Shed or MedVi?
Shed includes continuous coaching built into every treatment plan in the monthly price. MedVi provides 24/7 support from certified medical professionals, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
Do Shed or MedVi take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Shed or MedVi?
MedVi, with 12,896 against 8,500. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with Shed compared with MedVi?
Shed advertises 2-minute approval assessment, with home delivery after clinician review. MedVi advertises simple online process, no clinic visits, with fast, free shipping. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Are Shed and MedVi legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Shed operates on quoted only after intake with pricing quote only, after intake, MedVi on promotional first month, then standard rate, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; MedVi leads on a genuinely low promotional entry point with 24/7 clinical support behind it.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Neither choice is irreversible. Start with the program whose weaknesses you can tolerate, and reassess at month three when you know how you respond to the medication.
Keep comparing
- Shed vs MaximusPublished price vs quote-only
- Shed vs He & She MDPublished price vs quote-only
- MedVi vs EmbodyBudget vs premium
- MedVi vs RefillsBudget vs premium
- Wellorithm vs Sprout HealthPublished price vs quote-only
- Wellorithm vs Start WillowPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or MedVi, and does not sell treatment. Read our ranking methodology.